Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAllergy Thera. Regulatory News (AGY)

Share Price Information for Allergy Thera. (AGY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.90
Bid: 2.80
Ask: 3.00
Change: 0.00 (0.00%)
Spread: 0.20 (7.143%)
Open: 2.90
High: 3.00
Low: 2.84
Prev. Close: 2.90
AGY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holdings in Company

10 Jan 2018 15:19

RNS Number : 5221B
Allergy Therapeutics PLC
10 January 2018
 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Allergy Therapeutics PLC

LEI: 213800PQ7AHK7KGVOE23

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii: Placing of Shares

3. Details of person subject to the notification obligationiv

Name

Invesco Ltd.

City and country of registered office (if applicable)

1555 Peachtree Street NE, Suite 1800,

Atlanta, GA 30309 United States

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

09-01-2018

6. Date on which issuer notified (DD/MM/YYYY):

10-01-2018

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

4.81%

0

4.81%

594,117,768

Position of previous notification (if

applicable)

5.62%

0

5.62%

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

 

GB00B02LCQ05

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

28,618,373

4.81%

SUBTOTAL 8. A

28,618,373

4.81%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

X

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Invesco Asset

Management Limited.

4.81%

0

4.81%

 

 

 

10. In case of proxy voting, please identify:

Name of the proxy holder

Invesco (UK) Ltd.

The number and % of voting rights held

N/A

The date until which the voting rights will be held

N/A

11. Additional informationxvi

 

Place of completion

Henley-on-Thames

Date of completion

10-01-2018

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLEASFEFFPPEFF
Date   Source Headline
21st Aug 20238:21 amRNSForm 8.5 (EPT/RI)
18th Aug 20238:31 amRNSForm 8.5 (EPT/RI)
17th Aug 20238:40 amRNSForm 8.5 (EPT/RI)
16th Aug 20238:44 amRNSForm 8.5 (EPT/RI)
15th Aug 20238:51 amRNSForm 8.5 (EPT/RI)
14th Aug 20238:53 amRNSForm 8.5 (EPT/RI)
11th Aug 20238:44 amRNSForm 8.5 (EPT/RI)
10th Aug 20238:45 amRNSForm 8.5 (EPT/RI)
10th Aug 20237:00 amRNSTrading update for the year ended 30 June 2023
9th Aug 20238:44 amRNSForm 8.5 (EPT/RI)
8th Aug 20238:03 amRNSForm 8.5 (EPT/RI)
7th Aug 20239:39 amRNSForm 8.5 (EPT/RI)
4th Aug 20238:57 amRNSForm 8.5 (EPT/RI)
3rd Aug 20238:25 amRNSForm 8.5 (EPT/RI)
2nd Aug 20238:48 amRNSForm 8.5 (EPT/RI)
1st Aug 20238:26 amRNSForm 8.5 (EPT/RI)
31st Jul 20232:33 pmRNSResult of General Meeting
31st Jul 20238:28 amRNSForm 8.5 (EPT/RI)
28th Jul 20239:01 amRNSForm 8.5 (EPT/RI)
27th Jul 20238:25 amRNSForm 8.5 (EPT/RI)
26th Jul 20238:35 amRNSForm 8.5 (EPT/RI) - Allergy Therapeutics plc
25th Jul 20239:17 amRNSForm 8.5 (EPT/RI)
24th Jul 20238:15 amRNSForm 8.5 (EPT/RI)
21st Jul 20238:58 amRNSForm 8.5 (EPT/RI)
20th Jul 20238:09 amRNSForm 8.5 (EPT/RI)
19th Jul 20238:59 amRNSForm 8.5 (EPT/RI)
18th Jul 20238:19 amRNSForm 8.5 (EPT/RI)
17th Jul 20238:48 amRNSForm 8.5 (EPT/RI)
14th Jul 20238:36 amRNSForm 8.5 (EPT/RI)
13th Jul 20238:23 amRNSForm 8.5 (EPT/RI)
12th Jul 20238:44 amRNSForm 8.5 (EPT/RI)
11th Jul 20238:15 amRNSForm 8.5 (EPT/RI)
10th Jul 20231:12 pmRNSAppointment of Chief Financial Officer
10th Jul 20238:33 amRNSForm 8.5 (EPT/RI)
7th Jul 20238:28 amRNSForm 8.5 (EPT/RI)
6th Jul 20238:20 amRNSForm 8.5 (EPT/RI)
5th Jul 20238:45 amRNSForm 8.5 (EPT/RI)
4th Jul 20238:35 amRNSForm 8.5 (EPT/RI) - Allergy Therapeutics PLC
3rd Jul 20239:39 amRNSForm 8.5 (EPT/RI)
30th Jun 202312:08 pmRNSForm 8.5 (EPT/RI)
29th Jun 20238:31 amRNSForm 8.5 (EPT/RI)
28th Jun 20234:39 pmRNSForm 8.5 (EPT/RI)
28th Jun 20234:08 pmRNSForm 8.5 (EPT/RI) - Allergy Therapeutics PLC
28th Jun 20238:32 amRNSForm 8.5 (EPT/RI)
26th Jun 20239:25 amRNSForm 8.5 (EPT/RI)
23rd Jun 202311:48 amRNSForm 8.5 (EPT/RI)
23rd Jun 202310:48 amBUSForm 8.3 - The Allergy Therapeutics Plc
22nd Jun 20239:55 amBUSForm 8.3 - THE ALLERGY THERAPEUTICS PLC
22nd Jun 20238:45 amRNSForm 8.5 (EPT/RI)
21st Jun 20239:38 amRNSForm 8.5 (EPT/RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.